Vertex Announces Health Canada Acceptance for Suzetrigine NDS
Vertex Pharmaceuticals announced that Health Canada has accepted a New Drug Submission (NDS) for suzetrigine to treat moderate-to-severe acute pain in adults. If approved, the drug could represent the first new class of non-opioid and non-NSAID oral pain medicine in over two decades.
Tickers: $VRTX
Topics: Health Canada new drug submission pain treatment pharmaceuticals